
“Drugs companies publish only a fraction of their results and keep much of the information to themselves, but regulators want to ban the practice. If companies published all of their clinical trials data, independent scientists could reanalyse their results and check companies’ claims about the safety and efficacy of drugs. Under proposals being thrashed out in Europe, drugs companies would be compelled to release all of their data, including results that show drugs do not work or cause dangerous side-effects. The latest strategy shows how patient groups – many of which receive some or all of their funding from drugs companies – have been brought into the battle.”
Related posts:
Homeland Security's domain seizures worries Congress
Expat exodus from Spain as new tax law takes effect
Mexico ships first load of premium tequila to China
With military at ‘turning point,’ defense chief Leon Panetta avoids bold moves
At least six tanks leaking at military nuclear waste dump in Washington state
Google 'Donates' Millions For San Francisco Kids' City Bus Fares
Aussies start paying for beers in Bitcoin
Junk-Bond Funds Extend Losses as Lucidus Liquidates Holdings
Feeding Stray Cats In Philly Town Could Leave You Responsible For Their Health
Too much gold around the house? Store it at Texas' new precious metals depository
Colorado's Marijuana Legalization Campaign Goes To Court Over Deleted Text In Ballot Book
India: $1.2 million in gold bars found stashed in Boeing 737 bathroom
US sends Irish government arrest warrant for Snowden
U.S. suspends joint military operations with Afghanistan after insider attacks
Protesters block another Google bus, plan march against evictions